Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
>
2021
>
University of Oxford to begin testing AstraZeneca vaccine on children
University of Oxford to begin testing AstraZeneca vaccine on children
Read also
BMO most bullish on Merck’s, bearish on BMS’ plans to contend with patent cliffs
BMO Capital Markets favors Merck’s pipeline strategy to offset the Keytruda patent cliff over Bristol Myers Squibb's efforts to replace Opdivo and Eliquis.
Two-Drug Combo Supercharges Liver Cancer Therapy in Preclinical Study
A preclinical study demonstrates that combining regorafenib with experimental checkpoint inhibitor BMS-1 produces synergistic effects in liver cancer.
Sanofi and Regeneron expand immunology partnership to the tune of $8bn
Sanofi and Regeneron are expanding their immunology collaboration in a deal worth up to $8 billion to co-develop four new long-acting antibodies.
Bristol Myers Squibb secures expanded US approval for Camzyos
The US FDA has expanded the approval of Bristol Myers Squibb’s Camzyos to treat symptomatic obstructive hypertrophic cardiomyopathy in adolescents.
